BCL2 and gastric cancer: In addition, according to the target genes of miR-143 (ranked seventh in our prediction list), IGF1R and BCL2, which are related to cisplatin resistance, we can regulate the resistance of human gastric cancer cells to cisplatin via differential expression of IGF1R and BCL2 in gastric cancer tissues and cell lines [46].